ArticleOncotarget2018

Comprehensive immunotherapy combined with intratumoral injection of zoledronate-pulsed dendritic cells, intravenous adoptive activated T lymphocyte and gemcitabine in unresectable locally advanced pancreatic carcinoma: a phase I/II trial.

Yoshiki Hirooka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.